Antimicrobial Display Lighting Using Violet-Blue and IR Emission
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating infectious diseases and conditions using electromagnetic radiation, particularly UV light, pose risks to healthy cells and require longer treatment times, while existing LED-based solutions for microbial infection control are not optimized for rapid efficacy.
Innovation Solution
The use of LED-based antimicrobial lighting devices emitting wavelengths between 350-450 nm and IR radiation between 625-1200 nm, specifically 380-420 nm and 700-1200 nm, to directly target and kill infectious organisms within living species, mimicking a localized fever effect to enhance immune response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If UV light is used to treat infections, then antimicrobial effect is achieved, but damage to healthy cells occurs and treatment time is extended
Solution Approach 1:
The patent applies different wavelength ranges (350-450 nm for antimicrobial action, 625-1200 nm for thermal/immune support) to different functional requirements within the same treatment system, allowing selective targeting of pathogens while sparing healthy cells through wavelength-specific effects
Solution Approach 2:
The invention transitions from conventional UV wavelengths to optimized LED wavelength ranges (350-450 nm and 625-1200 nm), changing the physical parameters of electromagnetic radiation to achieve superior antimicrobial efficacy with reduced cytotoxicity and shorter treatment durations
2Reliability
If conventional LED-based antimicrobial lighting is used, then microbial infection control is achieved, but treatment time is prolonged and rapid efficacy is not obtained
Solution Approach 1:
The patent employs continuous emission of multiple wavelength ranges simultaneously (350-450 nm for direct pathogen kill, 625-1200 nm for immune modulation and thermal effects), maintaining constant therapeutic action to accelerate infection clearance compared to intermittent or single-wavelength conventional LEDs
Solution Approach 2:
The invention combines multiple LED wavelength components (violet-blue 350-450 nm and red-IR 625-1200 nm) into a composite lighting system that synergistically enhances antimicrobial efficacy and reduces treatment time through combined photobiomodulatory and thermal effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces and kills infections rapidly and safely, minimizing damage to healthy cells and tissues, leveraging the synergistic effects of antimicrobial and IR light to enhance immune function.
Implementation Method 1
The use of LED-based antimicrobial lighting devices emitting wavelengths between 350-450 nm and IR radiation between 625-1200 nm, specifically 380-420 nm and 700-1200 nm, to directly target and kill infectious organisms
Implementation Method 2
Light in the 380-420 nm wavelength is capable of killing or deactivating microorganisms such as but not limited to Gram positive bacteria, Gram negative bacteria, bacterial endospores, and yeast and filamentous fungi
Implementation Method 3
IR radiation between 625-1200 nm, specifically 700-1200 nm, to directly target and kill infectious organisms within living species, mimicking a localized fever effect
Implementation Method 4
individually using the IR electromagnetic radiation wavelengths to increase heat onto and/or near the infectious organisms
Data Source
AI summary
A light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices is disclosed. The light emitting device for video displays with anti-infective and therapeutic electromagnetic emission methods and devices uses non-visible and/or visible electromagnetic radiation on living species, including but not limited to people and animals, to provide treatments against infections and/or provide photobiomodulation treatments to improve health and wellness.